Anthony Rhodes
The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centres and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab
Rhodes, Anthony; Borthwick, Duncan; Sykes, Rob; Al-Sam, Salam; Paradiso, Angelo
Authors
Duncan Borthwick
Rob Sykes
Salam Al-Sam
Angelo Paradiso
Citation
Rhodes, A., Borthwick, D., Sykes, R., Al-Sam, S., & Paradiso, A. (2004). The use of cell line standards to reduce HER-2/neu assay variation in multiple European cancer centres and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab. American Journal of Clinical Pathology, 122, 51-60. https://doi.org/10.1309/E9B5-5JYH-D84L-8Y17
| Journal Article Type | Article |
|---|---|
| Publication Date | Jan 1, 2004 |
| Journal | American Journal of Clinical Pathology |
| Print ISSN | 1943-7722 |
| Publisher | Oxford University Press (OUP) |
| Peer Reviewed | Peer Reviewed |
| Volume | 122 |
| Pages | 51-60 |
| DOI | https://doi.org/10.1309/E9B5-5JYH-D84L-8Y17 |
| Keywords | cell line standards, cancer centres, automated image analysis, HER-2, neu, cell line standards, immunohistochemical assays, image analysis |
| Publisher URL | http://dx.doi.org/10.1309/E9B5-5JYH-D84L-8Y17 |